Publications by authors named "Richard Roque"

Claim this Profile
I
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2.
Jason P Laliberte, Yingyun Cai, Tara Kenny, Yi Zhang, Kuishu Ren, Richard Roque

NPJ Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses.
Johnathan D Guest, Yi Zhang, Daniel Flores, Emily Atkins, Kuishu Ren, Richard Roque

Vaccines (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.
Yueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, Michael E Abram, Anastasia A Aksyuk, Richard Roque

Sci Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope targeting with self-assembled peptide vaccines.
David F Zeigler, Emily Gage, Richard Roque, Christopher H Clegg

NPJ Vaccines· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a multivalent peptide vaccine for nicotine addiction.
David F Zeigler, Richard Roque, Christopher H Clegg

Vaccine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier.
Keith D Miller, Richard Roque, Christopher H Clegg

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.
David F Zeigler, Richard Roque, Christopher H Clegg

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.
Sean A Gray, Margaret Moore, Emily J VandenEkart, Richard P Roque, Richard A Bowen

Antiviral Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza.
Christopher H Clegg, Richard Roque, Lucy A Perrone, Joseph A Rininger, Richard Bowen

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models.
Cecile M Krejsa, Rick D Holly, Mark Heipel, Ken M Bannink, Rebecca Johnson, Richard Roque

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant solution for pandemic influenza vaccine production.
Christopher H Clegg, Richard Roque, Neal Van Hoeven, Lucy Perrone, Susan L Baldwin

Proc Natl Acad Sci U S A· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis